Flow diagram of participants selection. حسب Wei Huang (36889)

"…Finally, to assess the robustness of results, we conducted subgroup and sensivity analysis.…"

RM-ANOVA Post hoc Testing for PTS Across Time. حسب Rachel G. Baskin (22127334)

"…</p><p>Conclusions</p><p>Post-traumatic stress peaked in 2020 during lockdown in the United States and decreased significantly by 2022. Resilience and burnout did not change between 2020 and 2022. …"

Minimal data set. حسب Wei Huang (36889)

"…Finally, to assess the robustness of results, we conducted subgroup and sensivity analysis.…"

Weighted comparison of baseline characteristics. حسب Wei Huang (36889)

"…Finally, to assess the robustness of results, we conducted subgroup and sensivity analysis.…"

Box plot results for EphB4. حسب Romina Mastronicola (20978464)

"…This study aimed at comparing two methods (Reverse Transcription-Polymerase Chain Reaction and CellSearch) to detect circulating tumor cells (CTC) as a prognosticator. Results were statistically significant for markers EphB4 (p-value =  0.0003), CEA (p-value =  0.0006), CK 18 (p-value =  0.0011) and Ep-CAM (p-value =  0.0299) and demonstrate that our detection techniques could be used by optimizing our protocol. …"

Postnatal death of <i>aP2-Drp1</i>^f/f neonatal mice. حسب Yuta Ibayashi (20404811)

Human parasitology prevalence data. حسب Roland Proud (11764892)

Recruitment flow diagram of the current study. حسب Somayeh Momenyan (10111603)

"…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …"

Survival curve of ART Treatment outcomes. حسب Ekerette Emmanuel Udoh (7326194)

"…LTFU was shown to be low, decreasing significantly from 20.37 per 100PY in 2020 to 0.69 per 100PY in 2022. …"

Artwork demonstrating the principal tSCI compression subtypes. حسب Harshit Arora (22008280)

EPHPP tool quality assessment results. حسب Adeniyi Adeboye (21763205)

"…The study protocol was pre-registered on PROSPERO (CRD42023476867). Results showed significant improvements in mental health outcomes for PLWMI. …"

XXX. حسب Zhixuan Huang (6750410)

"…In the MCAO rat model, pretreatment with rutaecarpine significantly reduced neuronal death, decreased infarct volume, and improved neurological functional deficits. …"

Active ingredients of <i>Evodia rutaecarpa.</i> حسب Zhixuan Huang (6750410)

"…In the MCAO rat model, pretreatment with rutaecarpine significantly reduced neuronal death, decreased infarct volume, and improved neurological functional deficits. …"

S4 Minimal Data Set. Pzfx. حسب Ping-yu Cai (12389929)

"…In vivo efficacy of the miR-150-5p inhibitor was evaluated using HE, Masson staining, and immunofluorescence.</p><p>Results</p><p>In AS tissue exosomes, miR-150-5p levels increased whereas FoxO3a levels decreased. miR-150-5p regulated FoxO3a, enhancing macrophage pyroptosis. …"

Mortality dataset used in analysis. حسب Samuel Sendagala (21417164)

"…<div><p>Background</p><p>Uganda reported a significant reduction in the mortality rate of children under 5 years of age, from 146/1,000 live births in 2000–42/1,000 live births in 2021. …"

Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats. حسب Tobias G. Schips (21799838)

الموضوعات:

Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> حسب Tobias G. Schips (21799838)

الموضوعات:

Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. حسب Tobias G. Schips (21799838)

الموضوعات:

Hemodynamic effects of WT BMP9 in rats. حسب Tobias G. Schips (21799838)

الموضوعات:

Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. حسب Tobias G. Schips (21799838)

الموضوعات: